Learn more about the use of transcriptomics in safety prediction including:

• the challenges in translation from animals to humans, and how human cell-based models are now being routinely used in toxicology
• how transcriptomic analysis is showing promise in enhancing safety prediction and providing additional mechanistic information
• an overview of how Cyprotex, and parent company Evotec, are offering a fully customised end-to-end in vitro transcriptomics service using the latest next generation sequencing technology (RNA-seq) and a leading bioinformatics platform
• the use of sophisticated machine learning and artificial intelligence to interpret the large and complex datasets